Cargando…

Ingenuity pathway analysis of differentially expressed genes involved in signaling pathways and molecular networks in RhoE gene-edited cardiomyocytes

RhoE/Rnd3 is an atypical member of the Rho super-family of proteins, However, the global biological function profile of this protein remains unsolved. In the present study, a RhoE-knockout H9C2 cardiomyocyte cell line was established using CRISPR/Cas9 technology, following which differentially expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Zhongming, Wang, Keke, Zhang, Shuya, Yuan, Jianling, Liao, Xiaoming, Wu, Caixia, Zou, Yuan, Ha, Yanping, Shen, Zhihua, Guo, Junli, Jie, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388835/
https://www.ncbi.nlm.nih.gov/pubmed/32705255
http://dx.doi.org/10.3892/ijmm.2020.4661
_version_ 1783564379362426880
author Shao, Zhongming
Wang, Keke
Zhang, Shuya
Yuan, Jianling
Liao, Xiaoming
Wu, Caixia
Zou, Yuan
Ha, Yanping
Shen, Zhihua
Guo, Junli
Jie, Wei
author_facet Shao, Zhongming
Wang, Keke
Zhang, Shuya
Yuan, Jianling
Liao, Xiaoming
Wu, Caixia
Zou, Yuan
Ha, Yanping
Shen, Zhihua
Guo, Junli
Jie, Wei
author_sort Shao, Zhongming
collection PubMed
description RhoE/Rnd3 is an atypical member of the Rho super-family of proteins, However, the global biological function profile of this protein remains unsolved. In the present study, a RhoE-knockout H9C2 cardiomyocyte cell line was established using CRISPR/Cas9 technology, following which differentially expressed genes (DEGs) between the knockout and wild-type cell lines were screened using whole genome expression gene chips. A total of 829 DEGs, including 417 upregulated and 412 downregulated, were identified using the threshold of fold changes ≥1.2 and P<0.05. Using the ingenuity pathways analysis system with a threshold of -Log (P-value)>2, 67 canonical pathways were found to be enriched. Many of the detected signaling pathways, including that of oncostatin M signaling, were found to be associated with the inflammatory response. Subsequent disease and function analysis indicated that apart from cardiovascular disease and development function, RhoE may also be involved in other diseases and function, including organismal survival, cancer, organismal injury and abnormalities, cell-to-cell signaling and interaction, and molecular transport. In addition, 885 upstream regulators were enriched, including 59 molecules that were predicated to be strongly activated (Z-score >2) and 60 molecules that were predicated to be significantly inhibited (Z-scores <-2). In particular, 33 regulatory effects and 25 networks were revealed to be associated with the DEGs. Among them, the most significant regulatory effects were 'adhesion of endothelial cells' and 'recruitment of myeloid cells' and the top network was 'neurological disease', 'hereditary disorder, organismal injury and abnormalities'. In conclusion, the present study successfully edited the RhoE gene in H9C2 cells using CRISPR/Cas9 technology and subsequently analyzed the enriched DEGs along with their associated canonical signaling pathways, diseases and functions classification, upstream regulatory molecules, regulatory effects and interaction networks. The results of the present study should facilitate the discovery of the global biological and functional properties of RhoE and provide new insights into role of RhoE in human diseases, especially those in the cardiovascular system.
format Online
Article
Text
id pubmed-7388835
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-73888352020-08-05 Ingenuity pathway analysis of differentially expressed genes involved in signaling pathways and molecular networks in RhoE gene-edited cardiomyocytes Shao, Zhongming Wang, Keke Zhang, Shuya Yuan, Jianling Liao, Xiaoming Wu, Caixia Zou, Yuan Ha, Yanping Shen, Zhihua Guo, Junli Jie, Wei Int J Mol Med Articles RhoE/Rnd3 is an atypical member of the Rho super-family of proteins, However, the global biological function profile of this protein remains unsolved. In the present study, a RhoE-knockout H9C2 cardiomyocyte cell line was established using CRISPR/Cas9 technology, following which differentially expressed genes (DEGs) between the knockout and wild-type cell lines were screened using whole genome expression gene chips. A total of 829 DEGs, including 417 upregulated and 412 downregulated, were identified using the threshold of fold changes ≥1.2 and P<0.05. Using the ingenuity pathways analysis system with a threshold of -Log (P-value)>2, 67 canonical pathways were found to be enriched. Many of the detected signaling pathways, including that of oncostatin M signaling, were found to be associated with the inflammatory response. Subsequent disease and function analysis indicated that apart from cardiovascular disease and development function, RhoE may also be involved in other diseases and function, including organismal survival, cancer, organismal injury and abnormalities, cell-to-cell signaling and interaction, and molecular transport. In addition, 885 upstream regulators were enriched, including 59 molecules that were predicated to be strongly activated (Z-score >2) and 60 molecules that were predicated to be significantly inhibited (Z-scores <-2). In particular, 33 regulatory effects and 25 networks were revealed to be associated with the DEGs. Among them, the most significant regulatory effects were 'adhesion of endothelial cells' and 'recruitment of myeloid cells' and the top network was 'neurological disease', 'hereditary disorder, organismal injury and abnormalities'. In conclusion, the present study successfully edited the RhoE gene in H9C2 cells using CRISPR/Cas9 technology and subsequently analyzed the enriched DEGs along with their associated canonical signaling pathways, diseases and functions classification, upstream regulatory molecules, regulatory effects and interaction networks. The results of the present study should facilitate the discovery of the global biological and functional properties of RhoE and provide new insights into role of RhoE in human diseases, especially those in the cardiovascular system. D.A. Spandidos 2020-09 2020-06-26 /pmc/articles/PMC7388835/ /pubmed/32705255 http://dx.doi.org/10.3892/ijmm.2020.4661 Text en Copyright: © Shao et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Shao, Zhongming
Wang, Keke
Zhang, Shuya
Yuan, Jianling
Liao, Xiaoming
Wu, Caixia
Zou, Yuan
Ha, Yanping
Shen, Zhihua
Guo, Junli
Jie, Wei
Ingenuity pathway analysis of differentially expressed genes involved in signaling pathways and molecular networks in RhoE gene-edited cardiomyocytes
title Ingenuity pathway analysis of differentially expressed genes involved in signaling pathways and molecular networks in RhoE gene-edited cardiomyocytes
title_full Ingenuity pathway analysis of differentially expressed genes involved in signaling pathways and molecular networks in RhoE gene-edited cardiomyocytes
title_fullStr Ingenuity pathway analysis of differentially expressed genes involved in signaling pathways and molecular networks in RhoE gene-edited cardiomyocytes
title_full_unstemmed Ingenuity pathway analysis of differentially expressed genes involved in signaling pathways and molecular networks in RhoE gene-edited cardiomyocytes
title_short Ingenuity pathway analysis of differentially expressed genes involved in signaling pathways and molecular networks in RhoE gene-edited cardiomyocytes
title_sort ingenuity pathway analysis of differentially expressed genes involved in signaling pathways and molecular networks in rhoe gene-edited cardiomyocytes
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7388835/
https://www.ncbi.nlm.nih.gov/pubmed/32705255
http://dx.doi.org/10.3892/ijmm.2020.4661
work_keys_str_mv AT shaozhongming ingenuitypathwayanalysisofdifferentiallyexpressedgenesinvolvedinsignalingpathwaysandmolecularnetworksinrhoegeneeditedcardiomyocytes
AT wangkeke ingenuitypathwayanalysisofdifferentiallyexpressedgenesinvolvedinsignalingpathwaysandmolecularnetworksinrhoegeneeditedcardiomyocytes
AT zhangshuya ingenuitypathwayanalysisofdifferentiallyexpressedgenesinvolvedinsignalingpathwaysandmolecularnetworksinrhoegeneeditedcardiomyocytes
AT yuanjianling ingenuitypathwayanalysisofdifferentiallyexpressedgenesinvolvedinsignalingpathwaysandmolecularnetworksinrhoegeneeditedcardiomyocytes
AT liaoxiaoming ingenuitypathwayanalysisofdifferentiallyexpressedgenesinvolvedinsignalingpathwaysandmolecularnetworksinrhoegeneeditedcardiomyocytes
AT wucaixia ingenuitypathwayanalysisofdifferentiallyexpressedgenesinvolvedinsignalingpathwaysandmolecularnetworksinrhoegeneeditedcardiomyocytes
AT zouyuan ingenuitypathwayanalysisofdifferentiallyexpressedgenesinvolvedinsignalingpathwaysandmolecularnetworksinrhoegeneeditedcardiomyocytes
AT hayanping ingenuitypathwayanalysisofdifferentiallyexpressedgenesinvolvedinsignalingpathwaysandmolecularnetworksinrhoegeneeditedcardiomyocytes
AT shenzhihua ingenuitypathwayanalysisofdifferentiallyexpressedgenesinvolvedinsignalingpathwaysandmolecularnetworksinrhoegeneeditedcardiomyocytes
AT guojunli ingenuitypathwayanalysisofdifferentiallyexpressedgenesinvolvedinsignalingpathwaysandmolecularnetworksinrhoegeneeditedcardiomyocytes
AT jiewei ingenuitypathwayanalysisofdifferentiallyexpressedgenesinvolvedinsignalingpathwaysandmolecularnetworksinrhoegeneeditedcardiomyocytes